Skip to main content
TrimSoMoEverything GLP-1, in one place
Program Profile

Ro Body

Is Ro Body listed in FDA warning letters?

No GLP-1 FDA warning letters to Ro Body appear in our dataset (FDA.gov letters 2023–2026).

Key facts

  • •Care model: Telehealth care program.
  • •Medications discussed: Wegovy (semaglutide), Zepbound (tirzepatide), Wegovy Tablets (oral semaglutide), Foundayo (orforglipron), Saxenda (liraglutide).
  • •State availability: Confirm directly with program. Note: State availability was not confirmed in the reviewed source. Confirm directly with Ro before enrolling.

A telehealth weight-management program with clinician support.

At a glance
Care model
Telehealth care program
Medications discussed
Wegovy (semaglutide), Zepbound (tirzepatide), Wegovy Tablets (oral semaglutide), Foundayo (orforglipron), Saxenda (liraglutide)
Availability
Confirm with program
State availability was not confirmed in the reviewed source. Confirm directly with Ro before enrolling.

No FDA Warning Letters Found in Register

As of 2026-11-05, no FDA warning letters involving GLP-1 medications (semaglutide, tirzepatide) were identified in official FDA compliance records for this company or its operating corporate entities (Roman Health Ventures Inc.).

(Note: The absence of a warning letter in this dataset reflects public FDA records as of the date indicated and does not constitute a safety endorsement, certification of clinical quality, or operational guarantee.)

Questions to ask the program

Before you sign up

Read the program's own terms on its website, including how to cancel.

  • •Do the program terms change after the first month or refill?
  • •Are medication shipping and lab work handled by the program or separately?
  • •What notice does the program require to cancel?
Sources

Source records

Ro website

Last checked Nov 4, 2026

Open original source

Ro Wegovy Pill program page

Last checked Nov 7, 2026

Open original source

Ro Foundayo program page

Last checked Nov 7, 2026

Open original source
Pre-Enrollment Verification

Evaluate Eligibility & Coverage Before Enrolling in Ro Body

Confirm your clinical qualification and test out-of-pocket medication expenses before paying consultation or subscription fees to Ro Body.

All Decision Tools
Financial Modeling

Copay & Savings Card Rules

Model out-of-pocket copays for Zepbound and Wegovy under commercial plans ($25/mo caps) vs. self-pay cash channels.

Clinical Prep

Baseline Lab & Safety Screen

Legitimate telehealth prescribers require baseline kidney and A1c bloodwork. Review required panels and boxed warnings before your intake.

Indication Check

FDA BMI Indication Gauge

Verify whether your BMI meets official FDA prescribing standards (BMI ≥30 or ≥27 with comorbidity) before paying non-refundable fees.

100% Client-Side Privacy: No personal health data is shared with providers or third parties.Independent consumer guidance based on official DailyMed FDA prescribing archives.
Patient Guidance & Safety

Telehealth Navigation & Checklist

Evaluating a digital clinic? Review our clinical checklists for verifying state licensure, required blood work, and navigating insurance coverage.

Notice outdated or missing information? Submit a source-linked correction request.